Raised Interleukin‐6 Levels in Obese Patients
- 1 December 2000
- journal article
- clinical trial
- Published by Wiley in Obesity Research
- Vol. 8 (9), 673-675
- https://doi.org/10.1038/oby.2000.86
Abstract
Obese patients demonstrate a variety of biochemical, metabolic, and pulmonary abnormalities. Inflammatory mediators such as tumor necrosis factor-alpha and interleukin-6 (IL-6) may have a direct effect on glucose and lipid metabolism. Hypoxemia in itself induces release of IL-6. The aim of this study was to examine the relationship between IL-6 levels in healthy volunteers (control group) and three different groups of obese patients: patients without obstructive sleep apnea syndrome (OSAS), patients with OSAS, and patients with obesity hypoventilation syndrome (OHS) (daytime baseline oxygen saturation of 35 kg/m2) and 12 healthy women.The results demonstrate statistically significant differences in serum IL-6 levels between the control group (1.28 +/- 0.85 pg/mL) and obese patients without OSAS (7.69 +/- 5.06 pg/mL, p < 0.05) and with OSAS (5.58 +/- 0.37 pg/mL, p < 0.0005). In the patients with OHS, IL-6 concentrations were highest (43.13 +/- 24.27 pg/mL).We conclude that serum IL-6 is increased in obese patients. The highest IL-6 levels were found in the patients with OHS.Keywords
This publication has 16 references indexed in Scilit:
- The Differential Effect of Food Intake and -Adrenergic Stimulation on Adipose-Derived Hormones and Cytokines in ManJournal of Clinical Endocrinology & Metabolism, 1999
- Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by GlucocorticoidJournal of Clinical Endocrinology & Metabolism, 1998
- Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in VivoJournal of Clinical Endocrinology & Metabolism, 1997
- High Fat Diets Elevate Adipose Tissue-Derived Tumor Necrosis Factor-α Activity*Endocrinology, 1997
- Interleukin-6 in the Injured PatientAnnals of Surgery, 1996
- Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal SystemNew England Journal of Medicine, 1996
- Pathophysiology of obesityThe Lancet, 1992
- Stimulation of Interleukin‐6 mRNA Levels by Tumor Necrosis Factor and Interleukin‐1Annals of the New York Academy of Sciences, 1989
- ANAESTHESIA FOR THE MORBIDLY OBESEBritish Journal of Anaesthesia, 1981